SETDB1 modulates the TGFβ response in Duchenne muscular dystrophy myotubes

Alice Granados,Maeva Zamperoni,Roberta Rapone,Maryline Moulin,Ekaterina Boyarchuk,Costas Bouyioukos,Laurence Del Maestro,Véronique Joliot,Elisa Negroni,Myriame Mohamed,Sandra Piquet,Anne Bigot,Fabien Le Grand,Sonia Albini,Slimane Ait-Si-Ali
DOI: https://doi.org/10.1101/2023.06.28.546840
2024-01-18
Abstract:Overactivation of the TGFβ signaling in Duchenne muscular dystrophy (DMD) is a major hallmark of disease progression, leading to fibrosis and muscle dysfunction. Here, we investigated the role of SETDB1, a histone lysine methyltransferase involved in muscle differentiation. Our data show that, following TGFβ induction, SETDB1 accumulates in the nuclei of healthy myotubes, while being already present in the nuclei of DMD myotubes where TGFβ signaling is constitutively activated. Interestingly, transcriptomics revealed that depletion of SETDB1 in DMD myotubes leads to downregulation of TGFβ-target genes coding for secreted factors involved in extracellular matrix remodeling and inflammation. Consequently, SETDB1 silencing in DMD myotubes abrogates the deleterious effect of their secretome on myoblast differentiation by impairing myoblast pro-fibrotic response. Our findings indicate that SETDB1 potentiates the TGFβ-driven fibrotic response in DMD muscles, providing a new axis for therapeutic intervention.
Cell Biology
What problem does this paper attempt to address?